Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric ALL, B Cell”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT06871007
What this trial is testing

Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma

Who this might be right for
Primary Mediastinal (Thymic) Large B-cell LymphomaChildrenNivolumab
St. Petersburg State Pavlov Medical University 22
Not applicableNot Yet RecruitingNCT06763302
What this trial is testing

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

Who this might be right for
B Cell Precursor Acute Lymphoblastic LeukemiaPediatricMinimal Residual Disease+1 more
The Children's Hospital of Zhejiang University School of Medicine 1,220
Early research (Phase 1)Ended earlyNCT00101205
What this trial is testing

Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+24 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT03677128
What this trial is testing

Mobile Health Case Management System for Reducing Pediatric Treatment Abandonment

Who this might be right for
Burkitt LymphomaRetinoblastomaDiffuse Large B-cell Lymphoma
Duke University 75
Testing effectiveness (Phase 2)Study completedNCT01649765
What this trial is testing

Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 93
Large-scale testing (Phase 3)Study completedNCT02393859
What this trial is testing

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia, Acute Lymphoblastic
Amgen 111
Not applicableUnknownNCT05837689
What this trial is testing

Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
Xiaojun Xu 20
Early research (Phase 1)Study completedNCT02906371
What this trial is testing

Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome

Who this might be right for
Lymphoblastic Leukemia, Acute, Childhood
University of Pennsylvania 80
Testing effectiveness (Phase 2)Looking for participantsNCT06395103
What this trial is testing

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt Lymphoma+2 more
Merck Sharp & Dohme LLC 90
Early research (Phase 1)Looking for participantsNCT05476770
What this trial is testing

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAMLALL+8 more
Therapeutic Advances in Childhood Leukemia Consortium 54
Not applicableLooking for participantsNCT06579469
What this trial is testing

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Who this might be right for
B-ALLHematologic MalignancySolid Tumor
St. Jude Children's Research Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770698
What this trial is testing

Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic Leukemia+9 more
BeOne Medicines 30
Testing effectiveness (Phase 2)Study completedNCT01859819
What this trial is testing

Treatment for Advanced B-Cell Lymphoma

Who this might be right for
Diffuse Large Cell LymphomaBurkitt's LymphomaHigh Grade B-cell Lymphoma
New York Medical College 45
Early research (Phase 1)UnknownNCT04604691
What this trial is testing

Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)

Who this might be right for
Pediatric ALL, B CellMinimal Residual Disease
Seoul National University Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT03676504
What this trial is testing

Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR

Who this might be right for
Acute Lymphoblastic Leukemia, AdultAcute Lymphoblastic Leukemia, PediatricChronic Lymphocytic Leukemia+3 more
University Hospital Heidelberg 68
Early research (Phase 1)Study completedNCT00217412
What this trial is testing

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

Who this might be right for
Childhood Acute Promyelocytic Leukemia (M3)Childhood Atypical Teratoid/Rhabdoid TumorChildhood Burkitt Lymphoma+16 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Active Not RecruitingNCT05206357
What this trial is testing

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

Who this might be right for
Non-hodgkin Lymphoma
Genmab 17
Not applicableStudy completedNCT00801346
What this trial is testing

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

Who this might be right for
FatigueLeukemiaLong-term Effects Secondary to Cancer Therapy in Children
Vanderbilt University Medical Center 224
Testing effectiveness (Phase 2)Looking for participantsNCT06247501
What this trial is testing

Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation

Who this might be right for
Very High Risk Acute Lymphoblastic LeukemiaCD19 CAR-T Therapy
Seoul National University Hospital 50
Early research (Phase 1)Ended earlyNCT00313053
What this trial is testing

Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemiaAcute Lymphoid Leukemia (ALL)
Clare Twist 4
Next Page